Azilsartan medoxomil is a compound used as an active pharmaceutical ingredient. It is a prodrug that is converted to azilsartan in the body and acts as an angiotensin II receptor antagonist, primarily utilized in the manufacturing of medications for hypertension.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 863031-21-4
1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid ethyl ester
pharmaceutical intermediate
Desethyl Azilsartan Medoxomil
pharmaceutical raw material
1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester
pharmaceutical intermediate
Dasatinib monohydrate
pharmaceutical raw material
CJC-1295
pharmaceutical raw material
Cefodizime sodium
pharmaceutical raw material
Medetomidine
pharmaceutical raw material
Azilsartan kamedoxomil
active pharmaceutical ingredient
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
QJFSABGVXDWMIW-UHFFFAOYSA-N
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C